ALNY vs JILL · P/E 76, rev $1.29B vs P/E 7.2, rev $596.5M
Alnylam Pharmaceuticals Inc (ALNY) versus J.Jill Inc (JILL) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
J.Jill Inc (JILL) is a apparel retail company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported JILL revenue for 2026-01-31 was $596.5M. Net income was $27.9M. Revenue was down 2.3% from 2025-02-01 to 2026-01-31. JILL currently screens at market cap $195.0M and trailing P/E 7.2.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. JILL currently screens at market cap $195.0M and trailing P/E 7.2.
Not investment advice. Open the ALNY and JILL stock pages for the full models.
Not investment advice.